A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

Summary

The purpose of this study is to confirm that apricitabine does not induce any clinically significant effect upon electrocardiogram (ECG) parameters at doses consistent with the maximum exposure expected to occur in clinical practice.

Timeline

Start

2006-06

Primary completion

2006-08

Completion

2006-08

Drugs

Indications